{"id":29048,"date":"2026-04-07T10:17:53","date_gmt":"2026-04-07T10:17:53","guid":{"rendered":"https:\/\/www.medicalbillersandcoders.com\/blog\/?p=29048"},"modified":"2026-05-11T11:04:01","modified_gmt":"2026-05-11T11:04:01","slug":"why-hyperbaric-oxygen-therapy-billing-losing-revenue","status":"publish","type":"post","link":"https:\/\/www.medicalbillersandcoders.com\/blog\/why-hyperbaric-oxygen-therapy-billing-losing-revenue\/","title":{"rendered":"Why Is Hyperbaric Oxygen Therapy Billing Losing Your Wound Program Revenue?"},"content":{"rendered":"

Hyperbaric oxygen therapy billing is draining revenue from wound care programs across the country \u2014 not because of low patient volume, but because of three structural gaps that generic RCM vendors consistently fail to close: incorrect place-of-service coding, unsupported medical necessity documentation, and missed facility billing on the HCPCS G0277 line.<\/strong><\/p>\r\n

For multi-site wound care programs, hospital outpatient departments, and freestanding hyperbaric clinics, the financial exposure is significant.\u00a0A single denial cascade on HBOT claims can suppress Net Collection Ratio<\/a> by 6\u20139 percentage points \u2014 translating to $200K\u2013$400K in unrecovered revenue annually for programs running 10+ active chambers.<\/p>\r\n

The Three Revenue Threats Hidden in HBOT Claims<\/h2>\r\n

Threat 1: Place-of-Service Mismatch<\/h3>\r\n

Place-of-service (POS) codes directly affect reimbursement rates and denial rates \u2014 yet they remain one of the most common errors in hyperbaric oxygen therapy billing. Facility-based HBOT programs must report POS 22 (outpatient hospital) or POS 24 (ambulatory surgical center). Freestanding clinics use POS 11 (office).<\/p>\r\n

Mismatching POS to the billing entity triggers automatic payer edits and, in Medicare claims, flags the encounter for medical review.<\/p>\r\n

Threat 2: NCD 20.29 Documentation Gaps<\/h3>\r\n

Under CMS National Coverage Determination 20.29<\/a>, Medicare covers HBOT for 14 specific conditions.\u00a0For the most common wound care indication \u2014 diabetic wounds of the lower extremities \u2014 the criteria are precise: the patient must have Type 1 or Type 2 diabetes, the wound must be Wagner Grade III or higher, and there must be documented failure of standard wound care for at least 30 consecutive days with no measurable signs of healing.<\/p>\r\n

Every element must appear in the medical record before the first HBOT session is authorized and billed.\u00a0Per Noridian Medicare’s HBO guidance, wound evaluations must occur at minimum every 30 days during therapy to confirm ongoing medical necessity \u2014 a requirement frequently missed in high-volume programs, triggering retroactive denial of entire HBOT episodes.<\/p>\r\n

Threat 3: The CPT 99183 \/ G0277 Split<\/h3>\r\n

Physician supervision during HBOT is billed under CPT 99183 \u2014 one unit per session, regardless of session duration. Hospitals and HOPDs bill the facility component separately under HCPCS G0277.<\/p>\r\n

When both charges aren’t coordinated \u2014 or when the professional and facility bills submit under different diagnosis codes \u2014 payers interpret the inconsistency as a documentation failure and deny both claims.<\/p>\r\n

This dual-billing gap is where wound programs lose the most: each uncoordinated session represents lost reimbursement on two separate claim lines.<\/p>\r\n

For a deeper breakdown of code-level requirements, MBC’s HBOT Billing and Coding guide<\/a> covers the complete CPT\/HCPCS framework.<\/p>\r\n

HBOT Billing: Medicare vs. Commercial Payer Requirements<\/h2>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Requirement<\/strong><\/td>\r\nMedicare (NCD 20.29)<\/strong><\/td>\r\nCommercial Payers<\/strong><\/td>\r\n<\/tr>\r\n<\/thead>\r\n
Coverage basis<\/td>\r\n14 specific conditions only<\/td>\r\nVaries; often mirrors NCD 20.29<\/td>\r\n<\/tr>\r\n
Diabetic wound threshold<\/td>\r\nWagner Grade III+ required<\/td>\r\nGrade II accepted by some payers<\/td>\r\n<\/tr>\r\n
Prior authorization<\/td>\r\nNot required by Medicare; MAC-level variance<\/td>\r\nTypically required; often per-session<\/td>\r\n<\/tr>\r\n
Session documentation<\/td>\r\nEvery session + 30-day wound eval<\/td>\r\nVaries; some require weekly notes<\/td>\r\n<\/tr>\r\n
Facility billing code<\/td>\r\nHCPCS G0277<\/td>\r\nCPT 99183 (facility) or G0277<\/td>\r\n<\/tr>\r\n
Session limit (diabetic wounds)<\/td>\r\n30\u201340 sessions standard; extended with documentation<\/td>\r\n20\u201330 sessions typical; strict cap<\/td>\r\n<\/tr>\r\n
Topical oxygen coverage<\/td>\r\nExcluded from NCD; MAC discretion only<\/td>\r\nGenerally non-covered<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n

Where HBOT Revenue Integrity Breaks Down at Scale<\/h2>\r\n

Multi-site wound programs face a compounding problem:<\/strong> each facility may operate under a different MAC jurisdiction, with different LCD requirements layered on top of NCD 20.29. Noridian, CGS, and Palmetto GBA each publish distinct billing and coding articles for HBO therapy \u2014 and claim edits that pass in one jurisdiction may be auto-denied in another.<\/p>\r\n

Enterprise wound care programs running HBOT across multiple facilities need medical billing services<\/a> that are jurisdiction-aware \u2014 meaning every claim is validated against the MAC-specific LCD, not just the national NCD, before submission. Without this layer, programs routinely absorb denials that are appealed months later at 40\u201360 cents on the dollar.<\/p>\r\n

The HBOT Billing<\/a> fundamentals are well established \u2014 the revenue gap lies in execution at the enterprise level.<\/p>\r\n

The 90-Day Revenue Diagnostic: What We Find in HBOT Programs<\/h2>\r\n

MBC’s Revenue Diagnostic consistently surfaces the same patterns in wound programs relying on generic rcm services:<\/p>\r\n